Independent education resourceInformation here does not replace care from a qualified health professional.
Peptide Therapy GuideClear peptide education

Educational guide

ACE-031 and Anadrol Interaction: Monitor | Peptide Database

Compound Profiles ACE-031 Myostatin Inhibitor | Experimental Muscle Growth ACE-031 acts as a ligand trap for members of the TGF-beta superfamily. By mimicking the extracellular domain of the ActRIIB receptor, it intercepts myostatin (GDF-8), activin A, activin

Written by Peptide Therapy Guide Editorial Team
For education only

This guide cannot diagnose a condition or recommend a personal treatment plan. Discuss medical questions with a qualified professional.

Compound Profiles

ACE-031

Myostatin Inhibitor | Experimental Muscle Growth

ACE-031 acts as a ligand trap for members of the TGF-beta superfamily. By mimicking the extracellular domain of the ActRIIB receptor, it intercepts myostatin (GDF-8), activin A, activin B, and GDF-11 before they can bind cell-surface receptors and activate Smad2/3 signaling.

Anadrol

Oral Anabolic Steroid | Extreme Mass & Strength

Oxymetholone exerts its effects primarily through binding to the androgen receptor (AR) to promote protein synthesis and nitrogen retention in skeletal muscle. As a DHT derivative, it cannot be converted to estrogen by the aromatase enzyme.

Combined Organ Load

Shared Safety Flags

Frequently Asked Questions

Can I take ACE-031 with Anadrol?

Yes, but with caution. Both ACE-031 and Anadrol suppress the HPTA axis. Combined suppression deepens shutdown and extends recovery time. Plan PCT accordingly and monitor LH/FSH/testosterone. Regular monitoring is advised.

Is ACE-031 and Anadrol safe together?

Based on pharmacological analysis, this combination is considered monitor. However, shared safety flags include: androgenic, blood pressure raising, hpta suppressive, lipid disrupting, teratogenic. Monitor accordingly.

What are the interactions between ACE-031 and Anadrol?

Both ACE-031 and Anadrol suppress the HPTA axis. Combined suppression deepens shutdown and extends recovery time. Plan PCT accordingly and monitor LH/FSH/testosterone. This assessment has 46% confidence and is inferred from pharmacological mechanism analysis.

How should I time ACE-031 and Anadrol?

ACE-031 has a half-life of 12-15 days and Anadrol has a half-life of ~8-9 hours. No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.

This interaction analysis is compiled from research literature and pharmacological mechanism data. This assessment is inferred from known mechanisms and may not reflect all real-world outcomes. Always consult a healthcare professional before combining compounds.

Connected reading

Helpful context for this guide

Source-derived material selected through this article’s indexed topics.

comparison

Myostatin and Cardiomyocyte Hypertrophy: Physiological vs Pathological Contexts

The distinction between physiological and pathological cardiac hypertrophy is mechanistically critical for interpreting ACE-031’s cardiac biology. Physiological hypertrophy (exercise-induce…

Source: peptideslabuk.com
Research context

Read sources and limitations before applying a claim.

ACE-031 and Bone Density: Preclinical Evidence

Preclinical studies examining the skeletal effects of ActRIIB-Fc fusion proteins (including ACE-031 and related compounds) in rodent models have reported: Increased trabecular bone volume (BV/TV by micro-CT) in normal healthy mice after systemic ActRIIB-Fc administration, beyond levels attributable to mechanical loading from associated muscle hypertrophy — confirmed by studies in mechanically unloaded models Increased cortical bone thickness and improved biomechanical properties (three-point bending test peak load and stiffness) in ActRIIB-Fc treated animals Elevated bone formation rate (BFR/BS) by fluorochrome histomorphometry with normal osteoclast surface — indicating primarily anabolic rather than anti-resorptive mechanism In osteoporosis models (OVX rats), ActRIIB-Fc treatment partially prevents the trabecular bone loss that follows oestrogen withdrawal, with better preservation of BV/TV, Tb.N and Tb.Th compared with vehicle controls

Source: peptideslabuk.com ↗

ACE-031 and Immune Function Research

This article is prepared for researchers and laboratory scientists investigating growth factor receptor biology in immune contexts. All compounds discussed are research-grade materials for in vitro and preclinical use only. This content does not constitute medical advice or clinical guidance.

Source: peptideslabuk.com ↗
Practical and safety references

These excerpts are educational, not personalised medical instructions.

Dosage reference

ACE-031 Dosage, Reconstitution & Mixing Trends

See ACE-031 dosage trends, reconstitution volumes, and vial size patterns from anonymized WPA peptide calculator sessions. ACE-031 (ramatercept) is a soluble activin receptor type IIB-Fc fusion protein engineered to act as a myostatin trap, sequestering myostatin and related TGF-beta family ligands to permit muscle hypertrophy. Acceleron Pharma advanced it into Phase 2 trials in Duchenne muscular dystrophy that were halted on safety grounds. This data shows the dose amounts, vial sizes, and diluent volumes researchers most commonly select when working with ACE-031. 7 ACE-031 reconstitution calculations have been logged by the WPA community. The most common dose entered is 200mcg (3 calculations). The most common bacteriostatic water volume is 2mL. The most popular vial size is 10mg (5 sessions). The most common dosing frequency is once weekly (1 logged protocols). World Peptide Association aggregates anonymized peptide calculator data to show real-world dosing trends, reconstitution volumes, and vial size preferences across the research peptide community. All figures shown are aggregated from anonymized calculator inputs and are provided strictly for independent laboratory research and educational purposes. They are community usage statistics — not dosing recommendations, and not medical advice.

Source: worldpeptideassociation.com ↗
Storage reference

Usage and Storage:

ACE-031 is supplied as a lyophilised solid to ensure maximum stability and ease of use in research environments. For best results, follow our website's detailed reconstitution and storage guidelines.

Source: uk-peptides.com ↗
P

About the author

Peptide Therapy Guide Editorial Team

Editorial team for Peptide Therapy Guide.

View all articles →

Continue learning

Related guides